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Supplementary Figure 1.  
Structure-based sequence alignment of the WipB25-344 with WipA (PDB entry code 
5N6X), PP2B (PDB entry code 5C1V), PP2A (PDB entry code 2IAE) and PP1 (PDB 
entry code 5INB). Similar structures search was performed using the Dali server 1, 
selected top-scores aligned with PDBeFold 2 and the resulting alignment was rendered 
with ESPript 3. The WipB secondary structure elements are shown above the aligned 
sequences. Conserved phosphatase motifs are labeled DXH, GDxxDR, and NHE, and 
color-coded orange, green and blue, respectively. 
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Supplementary Figure 2: Structure of the asymmetric unit of WipB25-344 and 
comparison with WipA. 
a: The two chains seen in the asymmetric unit are coloured according to their Cα 
atoms B-factors. 
b: The two chains are represented in sticks, with the C-terminal part (280-344) in full 
colour. The electron density (calculated 2Fo-Fc coefficients and phases derived from 
the finally refined model) map is shown for the 280-344 residues (contoured at 1 
sigma) highlighting the lack of density for the end of chain A. A close-up view of the 
region where the chain ends is shown on the right. Some residues are labelled to help 
orientation. 
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c: Superposition between WipA and WipB. Both structures are shown in cartoon 
representation. Color-coding for WipB is as in Fig. 1C, while WipA is in grey. 
d: Structure-based sequence alignment of WipB and the human PPP phosphatase 
PP2B (PDB entry code 5C1V). Both are in semi-transparent cartoon representation, 
except for the conserved common parts of both structures that are not transparent. 
PP2B and WipB are in grey and purple, respectively. The orientation of the protein is 
the same as in Fig. 1C. 
e: Superposition between the catalytic sites of WipA (grey) and WipB (purple) in the 
same orientation and representation as in Fig. 2b. Residues in the catalytic sites are 
shown in ball-and-stick representations. However, only those in different positions 
when comparing the WipA and WipB structures are labelled, grey and purple for 
WipA and WipB, respectively. In WipA, Arg123 (185 in WipB), Asp31 (30 in WipB) 
and Asp331 (396 in WipB) are involved in catalysis while Arg369 of WipA was 
hypothesized to be involved in pTyr recognition. In WipB, the equivalent residue of 
Arg369 is Arg310, which is conformationally restrained away from the active site and 
therefore cannot assume a role in substrate recognition. We hypothesize that this is 
the reason why WipB is inactive against pTyr-containing peptides (see main text).  
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Supplementary Figure 3: Expression of GFP, GFP-WipB and GFP-WipB 
derivatives in cultured mammalian cells. 
a: SDS-PAGE of HeLa cell lysates following transfection with GFP, GFP-WipB or 
the indicated GFP-WipB derivatives and immunoblotting using an anti-GFP antibody. 
Eukaryotic Sec61 is included as a loading control. 
Prevost et al. (2017) Supplementary Information 
	   6	  
b: Cultured HeLa cells expressing WipB-GFP (green). Scale bar, 25 µm. 
c: Cultured RPE-1 cells expressing WipB-GFP (green). Scale bar, 25 µm. 
d: HeLa cells expressing GFP-WipB or GFP-WipBD118A (green) were loaded with 
TRITC-Dextran 10,000 (red) for 15 before fixation. Scale bar, 10 µm. 
e: Quantitative analysis of colocalisation between GFP-WipB and the cellular markers 
as show in Fig. 3 and Fig. S3, considering the extent of colocalisation of GFP-WipB 
signal with the markers (left), or conversely the extent of colocalisation of the 
markers with GFP-WipB (right). *, ** and *** indicate P values < 0.05, < 0.01, < 
0.001, respectively, and were calculated employing an unpaired t-test.  
f: HeLa cells expressing GFP-WipBD118A (green) were loaded with Lysotracker (red) 
for 15 min before fixation or stained using an anti-LAMP-1 antibody (magenta) after 
permeabilisation and fixation. Scale bar, 10 µm. 
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Supplementary Figure 4: Localisation of GFP-WipB in cultured cells 
HeLa cells expressing GFP-WipB (green) were fixed and stained with an anti-giantin 
or anti-calreticulin antibody (red), prior to fixation with Mitotracker (red), or loaded 
with transferrin (magenta). Scale bars, 10µm. 
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Supplementary Figure 5: Immunoprecipitation of GFP-WipB and LYNUS 
components 
a: SDS-PAGE of HeLa cell lysates (input) following transfection with GFP, GFP-
WipB or the indicated GFP-WipB derivatives and immunoblotting with anti-GFP 
antibody. 
b: SDS-PAGE of HeLa cell lysates (input) for the immunoprecipitation experiments 
using anti-v-ATPase A, anti-v-ATPase B and anti-LAMTOR antibodies shown in Fig. 
4E, following immunoblotting with anti-GFP antibody. Identical lysate samples were 
blotted with anti-Sec61 as a loading control.  
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Unmodified scans of the gel and blots displayed in the article  
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Figure 3d 
The membrane was cut in 3 horizontal strips around the molecular weight of the 
protein of interest (v-ATPase A, 68kDa; v-ATPase B, 57kDa; LAMTOR1, 17kDa). 
Each strip was incubated with the corresponding primary antibody, then the 
secondary HRP-conjugated antibody, and finally the ECL reagents. The 3 strips were 
then re-assembled carefully before exposure. 
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Figure 3e 
The membrane was cut in 5 horizontal strips around the molecular weight of the 
protein of interest (v-ATPase A, 68kDa; v-ATPase B, 57kDa; LAMTOR1, 17kDa; 
GFP 86kDa and 30kDa). Each strip was incubated with the corresponding primary 
antibody, then the secondary HRP-conjugated antibody, and finally the ECL reagents. 
The 5 strips were then re-assembled carefully before exposure. 
 
 
 
 
Figure S3a 
The membrane was cut in 2 horizontal strips around the molecular weight of the 
protein of interest (GFP, from 20kDa to top, Sec61 from 20kDa to bottom). Each strip 
was incubated with the corresponding primary antibody, then the secondary HRP-
conjugated antibody, and finally the ECL reagents. The 2 strips were then re-
assembled carefully before exposure. 
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Figure S5a 
 
 
 
 
Figure S5b 
The membrane was cut in 2 horizontal strips around the molecular weight of the 
protein of interest (GFP, from 20kDa to top, Sec61 from 20kDa to bottom). Each strip 
was incubated with the corresponding primary antibody, then the secondary HRP-
conjugated antibody, and finally the ECL reagents. The 2 strips were then re-
assembled carefully before exposure. 
 
